Total Payments
$3,315
2024 Payments
$367.47
Companies
32
Transactions
189
Medicare Patients
2,548
Medicare Billing
$162,321
Payment Breakdown by Category
Food & Beverage$3,315 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,315 | 189 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $533.33 | 27 | $0 (2024) |
| Novo Nordisk Inc | $505.54 | 38 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $258.14 | 3 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $209.61 | 10 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $200.78 | 14 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $197.03 | 12 | $0 (2022) |
| Amgen Inc. | $170.61 | 10 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $166.28 | 9 | $0 (2022) |
| Lilly USA, LLC | $150.35 | 10 | $0 (2024) |
| Eisai Inc. | $104.60 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $367.47 | 12 | ABBVIE INC. ($177.82) |
| 2023 | $430.05 | 19 | Merz North America, Inc. ($121.17) |
| 2022 | $728.76 | 45 | ABBVIE INC. ($208.14) |
| 2021 | $1,284 | 79 | Novo Nordisk Inc ($182.84) |
| 2020 | $504.39 | 34 | Novo Nordisk Inc ($100.00) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $70.00 | General |
| 04/11/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.33 | General |
| 04/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $136.97 | General |
| Category: Dermatology | ||||||
| 02/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Obesity | ||||||
| 01/23/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Obesity | ||||||
| 01/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.39 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Diabetes | ||||||
| 11/01/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $86.49 | General |
| Category: Dermatology | ||||||
| 10/03/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Oncology | ||||||
| 09/28/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Diabetes | ||||||
| 08/24/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Diabetes | ||||||
| 08/23/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Diabetes | ||||||
| 08/02/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $34.68 | General |
| Category: Dermatology | ||||||
| 07/26/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: VACCINES | ||||||
| 07/12/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: Inflammation | ||||||
| 06/05/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: VACCINES | ||||||
| 05/25/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Diabetes | ||||||
| 05/01/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 13 | 404 | 720 | $64,182 | $19,965 |
| 2021 | 29 | 1,348 | 2,835 | $237,286 | $92,716 |
| 2020 | 16 | 796 | 1,394 | $121,874 | $49,640 |
Total Patients
2,548
Total Services
4,949
Medicare Billing
$162,321
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 140 | 201 | $44,220 | $10,376 | 23.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 23 | 92 | $5,720 | $2,988 | 52.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 24 | 24 | $3,400 | $2,686 | 79.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 13 | 13 | $2,925 | $1,947 | 66.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 13 | $2,054 | $617.31 | 30.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 11 | 11 | $715.00 | $387.93 | 54.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 24 | 24 | $1,200 | $370.26 | 30.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 71 | 94 | $1,128 | $278.04 | 24.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 35 | $1,225 | $176.29 | 14.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 19 | 22 | $220.00 | $49.32 | 22.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 19 | 78 | $936.00 | $46.12 | 4.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 20 | 50 | $250.00 | $38.56 | 15.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 15 | 63 | $189.00 | $4.05 | 2.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 269 | 714 | $157,080 | $55,302 | 35.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 35 | 305 | $15,250 | $8,184 | 53.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 63 | $9,954 | $3,574 | 35.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 28 | 28 | $3,640 | $3,518 | 96.6% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 84 | 94 | $6,110 | $3,286 | 53.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 50 | 50 | $3,440 | $3,064 | 89.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 19 | 21 | $4,914 | $2,895 | 58.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 12 | 12 | $2,700 | $1,917 | 71.0% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 33 | 68 | $2,040 | $1,125 | 55.2% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 30 | 30 | $1,200 | $1,109 | 92.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 32 | 123 | $4,305 | $1,004 | 23.3% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 27 | 27 | $1,080 | $997.65 | 92.4% |
About Dr. Lisa Seawright, DO
Dr. Lisa Seawright, DO is a Family Medicine healthcare provider based in Hartwell, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2013. The National Provider Identifier (NPI) number assigned to this provider is 1265872840.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lisa Seawright, DO has received a total of $3,315 in payments from pharmaceutical and medical device companies, with $367.47 received in 2024. These payments were reported across 189 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,315).
As a Medicare-enrolled provider, Seawright has provided services to 2,548 Medicare beneficiaries, totaling 4,949 services with total Medicare billing of $162,321. Data is available for 3 years (2020–2022), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Hartwell, GA
- Active Since 06/27/2013
- Last Updated 08/29/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265872840
Products in Payments
- Ozempic (Drug) $322.08
- UBRELVY (Drug) $320.07
- Xeomin (Biological) $258.14
- FARXIGA (Drug) $189.72
- TRINTELLIX (Drug) $176.41
- QULIPTA (Drug) $131.02
- JARDIANCE (Drug) $113.39
- Dayvigo (Drug) $104.60
- SOLIQUA 100/33 (Biological) $102.37
- Aimovig (Biological) $98.54
- TRELEGY ELLIPTA (Drug) $92.43
- Rybelsus (Drug) $91.18
- TRADJENTA (Drug) $91.02
- NURTEC ODT (Drug) $90.16
- Otezla (Drug) $72.07
- TOUJEO (Biological) $63.91
- RYBELSUS (Drug) $61.64
- ZENPEP (Drug) $53.57
- MOUNJARO (Drug) $50.55
- AJOVY (Biological) $49.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hartwell
Emory Walker, M.d, M.D
Family Medicine — Payments: $10,509
Family Medicine $10,509
Jodon Garringer, M.d, M.D
Family Medicine — Payments: $8,587
Family Medicine $8,587
Dr. Bradley White, D.o, D.O
Family Medicine — Payments: $8,338
Family Medicine $8,338
Dr. Edward Wysong, M.d, M.D
Family Medicine — Payments: $4,318
Family Medicine $4,318
Anthony Lau, Md, MD
Family Medicine — Payments: $2,936
Family Medicine $2,936
Jenean White, Md, MD
Family Medicine — Payments: $2,616
Family Medicine $2,616